BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH

被引:2975
作者
BOISE, LH
GONZALEZGARCIA, M
POSTEMA, CE
DING, LY
LINDSTEN, T
TURKA, LA
MAO, XH
NUNEZ, G
THOMPSON, CB
机构
[1] UNIV CHICAGO, HOWARD HUGHES MED INST, DEPT MOLEC GENET & CELL BIOL, CHICAGO, IL 60637 USA
[2] UNIV MICHIGAN, SCH MED, DEPT PATHOL, ANN ARBOR, MI 48109 USA
[3] UNIV MICHIGAN, SCH MED, DEPT MED, ANN ARBOR, MI 48109 USA
关键词
D O I
10.1016/0092-8674(93)90508-N
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the isolation of bcl-x, a bcl-2-related gene that can function as a bcl-2-independent regulator of programed cell death (apoptosis). Alternative splicing results in two distinct bcl-x mRNAs. The protein product of the larger mRNA, bcl-x(L), is similar in size and predicted structure to Bcl-2. When stably transfected into an IL-3-dependent cell line, bcl-x(L) inhibits cell death upon growth factor with drawal at least as well as bcl-2. Surprisingly, the second mRNA species, bcl-x(s), encodes a protein that inhibits the ability of bcl-2 to enhance the survival of growth factor-deprived cells. In vivo, bcl-x(s) mRNA is expressed at high levels in cells that undergo a high rate of turnover, such as developing lymphocytes. In contrast, bcl-x(L) is found in tissues containing long-lived postmitotic cells, such as adult brain. Together these data suggest that bcl-x plays an important role in both positive and negative regulation of programed cell death.
引用
收藏
页码:597 / 608
页数:12
相关论文
共 43 条
[1]   THE PROTOONCOGENE BCL-2 CAN SELECTIVELY RESCUE NEUROTROPHIC FACTOR-DEPENDENT NEURONS FROM APOPTOSIS [J].
ALLSOPP, TE ;
WYATT, S ;
PATERSON, HF ;
DAVIES, AM .
CELL, 1993, 73 (02) :295-307
[2]   CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18 [J].
BAKHSHI, A ;
JENSEN, JP ;
GOLDMAN, P ;
WRIGHT, JJ ;
MCBRIDE, OW ;
EPSTEIN, AL ;
KORSMEYER, SJ .
CELL, 1985, 41 (03) :899-906
[3]   THE ROLE OF THE T-CELL RECEPTOR IN POSITIVE AND NEGATIVE SELECTION OF DEVELOPING T-CELLS [J].
BLACKMAN, M ;
KAPPLER, J ;
MARRACK, P .
SCIENCE, 1990, 248 (4961) :1335-1341
[4]  
BORZILLO GV, 1992, ONCOGENE, V7, P869
[5]   MOLECULAR-CLONING AND DNA-SEQUENCE ANALYSIS OF CDNA-ENCODING CHICKEN HOMOLOG OF THE BCL-2-ONCOPROTEIN [J].
CAZALSHATEM, DL ;
LOUIE, DC ;
TANAKA, S ;
REED, JC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1132 (01) :109-113
[6]   THE BCL-2 CANDIDATE PROTO-ONCOGENE PRODUCT IS A 24-KILODALTON INTEGRAL-MEMBRANE PROTEIN HIGHLY EXPRESSED IN LYMPHOID-CELL LINES AND LYMPHOMAS CARRYING THE T(14,18) TRANSLOCATION [J].
CHENLEVY, Z ;
NOURSE, J ;
CLEARY, ML .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :701-710
[7]  
CHLEQDESCHAMPS CM, 1993, BLOOD, V81, P293
[8]   CLONING AND STRUCTURAL-ANALYSIS OF CDNAS FOR BCL-2 AND A HYBRID BCL-2/IMMUNOGLOBULIN TRANSCRIPT RESULTING FROM THE T(14-18) TRANSLOCATION [J].
CLEARY, ML ;
SMITH, SD ;
SKLAR, J .
CELL, 1986, 47 (01) :19-28
[9]  
COOPER MD, 1991, ADV IMMUNOL, V50, P87
[10]   REGRESSIVE EVENTS IN NEUROGENESIS [J].
COWAN, WM ;
FAWCETT, JW ;
OLEARY, DDM ;
STANFIELD, BB .
SCIENCE, 1984, 225 (4668) :1258-1265